Recurring large deletion in DRC1 (CCDC164) identified as causing primary ciliary dyskinesia in two Asian patients.
Asian
/ genetics
Base Sequence
/ genetics
Bronchiolitis
/ diagnosis
Child, Preschool
Ciliary Motility Disorders
/ genetics
Cohort Studies
DNA Mutational Analysis
/ methods
Exons
/ genetics
Feasibility Studies
Female
Founder Effect
Genetic Testing
/ methods
Haemophilus Infections
/ diagnosis
Heterozygote
Homozygote
Humans
Japan
/ ethnology
Male
Microtubule-Associated Proteins
/ genetics
Middle Aged
North Carolina
Polymerase Chain Reaction
Republic of Korea
/ ethnology
Sequence Deletion
DRC1
Asia
diffuse panbronchiolitis
primary ciliary dyskinesia
recurrent mutation
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
22
02
2019
revised:
16
04
2019
accepted:
18
05
2019
pubmed:
5
7
2019
medline:
1
7
2020
entrez:
5
7
2019
Statut:
ppublish
Résumé
Primary ciliary dyskinesia (PCD) is a relatively rare autosomal recessive or X-linked disorder affecting ciliary function. In the set of causative genes, however, predominant pathogenic variants remain unknown in Asia. A diagnosis of PCD was made following a modern comprehensive testing including genetic analysis; targeted resequencing for screening variants, and Sanger sequencing for determination of the breakpoints, with an additional review of databases to calculate the deletion frequency. A multiplexed PCR-based detection method has also been developed. We ascertained a 50-year-old Japanese male who had been diagnosed with diffuse panbronchiolitis (DPB), but refractory to macrolide therapy. We reevaluated the case and identified a large homozygous deletion spanning exons 1 to 4 of the DRC1 and determined the breakpoints (NM_145038.4: c.1-3952_540 + 1331del27748-bp). In the PCD cohort at the University of North Carolina, we found a female PCD patient of Korean descent harboring the same homozygous deletion. From the Invitae testing cohort, we extracted four carriers of the same deletion among 965 Asian individuals, whereas no deletion was found in the 23,951 non-Asians. We speculate that the DRC1 deletion is a recurrent or perhaps founder mutation in Asians. The simple PCR method could be a useful screening tool.
Sections du résumé
BACKGROUND
Primary ciliary dyskinesia (PCD) is a relatively rare autosomal recessive or X-linked disorder affecting ciliary function. In the set of causative genes, however, predominant pathogenic variants remain unknown in Asia.
METHOD
A diagnosis of PCD was made following a modern comprehensive testing including genetic analysis; targeted resequencing for screening variants, and Sanger sequencing for determination of the breakpoints, with an additional review of databases to calculate the deletion frequency. A multiplexed PCR-based detection method has also been developed.
RESULTS
We ascertained a 50-year-old Japanese male who had been diagnosed with diffuse panbronchiolitis (DPB), but refractory to macrolide therapy. We reevaluated the case and identified a large homozygous deletion spanning exons 1 to 4 of the DRC1 and determined the breakpoints (NM_145038.4: c.1-3952_540 + 1331del27748-bp). In the PCD cohort at the University of North Carolina, we found a female PCD patient of Korean descent harboring the same homozygous deletion. From the Invitae testing cohort, we extracted four carriers of the same deletion among 965 Asian individuals, whereas no deletion was found in the 23,951 non-Asians.
CONCLUSION
We speculate that the DRC1 deletion is a recurrent or perhaps founder mutation in Asians. The simple PCR method could be a useful screening tool.
Identifiants
pubmed: 31270959
doi: 10.1002/mgg3.838
pmc: PMC6687623
doi:
Substances chimiques
DRC1 protein, human
0
Microtubule-Associated Proteins
0
Types de publication
Case Reports
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e838Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL071798
Pays : United States
Organisme : NCATS NIH HHS
ID : U2C TR002818
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL096458
Pays : United States
Informations de copyright
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Références
Clin Chest Med. 2016 Sep;37(3):449-61
pubmed: 27514592
Am J Respir Crit Care Med. 2018 Jun 15;197(12):e24-e39
pubmed: 29905515
Ultrastruct Pathol. 2017 Nov-Dec;41(6):373-385
pubmed: 28915070
Auris Nasus Larynx. 2018 Jun;45(3):585-591
pubmed: 28939216
Nat Genet. 2013 Mar;45(3):262-8
pubmed: 23354437
Am J Hum Genet. 2000 Feb;66(2):501-7
pubmed: 10677310
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1829-32
pubmed: 9620913
Mol Genet Genomic Med. 2019 Aug;7(8):e838
pubmed: 31270959
Respirology. 2011 May;16(4):581-8
pubmed: 21303426